Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial

OBJECTIVE: To evaluate if COmbinatie therapie Bij Reumatoïde Artritis (COBRA)-light therapy is cost-effective in treating patients with early rheumatoid arthritis (RA) compared with COBRA therapy. METHODS: This economic evaluation was performed next to the open-label, randomised non-inferiority COBR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:RMD Open
Autors principals: ter Wee, Marieke M, Coupé, Veerle MH, den Uyl, Debby, Blomjous, Birgit S, Kooijmans, Esmee, Kerstens, Pit JSM, Nurmohamed, Mike T, van Schaardenburg, Dirkjan, Voskuyl, Alexandre E, Boers, Maarten, Lems, Willem F
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2017
Matèries:
Rheumatoid Arthritis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663254/
https://ncbi.nlm.nih.gov/pubmed/29119006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000502
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars